HISTOLOGIC CHARACTERIZATION OF UTERINE PAPILLARY SEROUS ADENOCARCINOMA

被引:14
作者
MILLER, B
UMPIERRE, S
TORNOS, C
BURKE, T
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT GYNECOL ONCOL,HOUSTON,TX 77025
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77025
关键词
D O I
10.1006/gyno.1995.1075
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine papillary serous adenocarcinoma (UPSC) is one of the most aggressive endometrial tumors. UPSC has been associated with an increased propensity for extrauterine spread. Survival rates of not more than 50% are commonly reported even for tumors which appear to be confined to the uterus. Small areas of UPSC can be found in otherwise well-differentiated endometrial lesions and yet still determine the overall prognosis. In the present study we evaluated histologic criteria that might be helpful in diagnosing small-volume UPSC, including silver-stained nucleolar organizer regions (AgNOR) which have prognostic importance in a variety of tumors, and nuclear size which has been used for prognostication in endometrial cancer. We examined 25 UPSC specimens and compared them to grade III (GIII, n = 10) and grade I (GI, n = 10) typical endometrial adenocarcinoma using the following parameters: mean AgNOR count per cell was UPSC 6, GIII 6.0, and GI 4.3; mean AgNOR area was UPSC 1.28 mum2, GIII 1.35 mum2, and GI 0.86 mum2; total AgNOR area per cell was UPSC 7.5 mum2, GIII 8.13 mum2, GI 4.47 mum2; and nuclear size was UPSC 66.9 mum2, GIII 60.3 mum2, GI 34.8 mum2. All differences between UPSC or GIII tumors and GI lesions were statistically significant. Overexpression of p53, as determined histochemically, was seen in 64% of the UPSC specimens. UPSC is characterized by high AgNOR count and area per cell, large nuclear size, and a high rate of p53 overexpression. Evaluation of these parameters in biopsy material may aid in selecting high-risk patients for adjuvant therapy trials. (C) 1995 Academic Press, Inc.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 24 条
[1]  
BAAK JPA, 1991, QUANTITATIVE PATHOLO, P332
[2]  
BERCHUCK A, 1994, AM J OBSTET GYNECOL, V170, P246
[3]   UTERINE PAPILLARY SEROUS CARCINOMA - A STUDY ON 108 CASES WITH EMPHASIS ON THE PROGNOSTIC-SIGNIFICANCE OF ASSOCIATED ENDOMETRIOID CARCINOMA, ABSENCE OF INVASION, AND CONCOMITANT OVARIAN-CARCINOMA [J].
CARCANGIU, ML ;
CHAMBERS, JT .
GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :298-305
[4]  
GALLION HH, 1989, CANCER, V63, P2224, DOI 10.1002/1097-0142(19890601)63:11<2224::AID-CNCR2820631128>3.0.CO
[5]  
2-7
[6]   IMMUNOHISTOCHEMICAL STUDY OF P53 EXPRESSION IN ENDOMETRIAL CARCINOMAS - CORRELATION WITH MARKERS OF PROLIFERATING CELLS AND CLINICOPATHOLOGICAL FEATURES [J].
HACHISUGA, T ;
FUKUDA, K ;
UCHIYAMA, M ;
MATSUO, N ;
IWASAKA, T ;
SUGIMORI, H .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (06) :363-368
[7]   REVIEW - ASSESSMENT OF CELL-PROLIFERATION IN HISTOLOGICAL MATERIAL [J].
HALL, PA ;
LEVISON, DA .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (03) :184-192
[8]   UTERINE PAPILLARY SEROUS CARCINOMA - A HIGHLY MALIGNANT FORM OF ENDOMETRIAL ADENOCARCINOMA [J].
HENDRICKSON, M ;
ROSS, J ;
EIFEL, P ;
MARTINEZ, A ;
KEMPSON, R .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (02) :93-108
[9]  
KOHLER MF, 1992, CANCER RES, V52, P1622
[10]  
LEE KR, 1991, AM J SURG PATHOL, V15, P965